Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF

Figure 1

Analysis of key components and core targets of SSLF therapy for RIF based on network pharmacology. (a) Venn diagram of the intersection gene between SSLF and RIF target. (b) Venn diagram of the target intersection gene. (c) Protein-protein interaction network. Edges represent protein-protein interactions. (d) SSLF-compound-target-RIF network. In this network, the blue diamonds represent candidate targets of SSLF against RIF, and the yellow hexagon represents active compounds in SSLF.

(a)

(b)

(c)

(d)